RH is in a recovery uptrend from its 52-week low of $106.30, but remains down 22.5% over the past year. The current price of $165.35 sits at 64% of the 52-week range ($106.30–$257.00), indicating a rebound from the lows but still well below the highs. This positioning suggests the stock is in a recovery phase, with potential upside if momentum continues, but it has not yet reclaimed the highs that would signal a full trend reversal. Short-term momentum is strong, with a 1-month gain of 11.2% and a 3-month gain of 31.7%, significantly outperforming the S&P 500's 1-month and 3-month returns of 4.1% and 11.1%, respectively. The 1-month relative strength of 7.1% confirms near-term outperformance, but the 1-year relative strength of -43.2% highlights the long-term underperformance. This divergence suggests a potential trend reversal or mean reversion, as the stock is recovering from oversold conditions. The 52-week low of $106.30 provides strong support, while the 52-week high of $257.00 acts as key resistance. A breakout above $257 would signal a resumption of the long-term uptrend, while a breakdown below $106.30 would indicate further downside. With a beta of 1.876, RH is 87.6% more volatile than the market, amplifying both upside and downside moves, which is critical for risk management.

Revenue has shown modest growth, with the most recent quarter (Q4 FY2025, ended Jan 31, 2026) reporting $842.6 million, up 3.7% year-over-year from $812.4 million in the prior-year quarter. However, the multi-quarter trend shows deceleration: Q3 FY2025 revenue was $883.8 million (up 8.9% YoY), Q2 FY2025 was $899.2 million (up 8.4% YoY), and Q1 FY2025 was $814.0 million (up 12.0% YoY). The RH segment contributed $846.7 million and Waterworks $52.4 million, indicating core RH drives the business. The growth trajectory is slowing, which may temper investor enthusiasm. Profitability is positive but thin: net income for Q4 FY2025 was $28.8 million, with a net margin of 3.4%. Gross margin was 42.9%, stable compared to 44.7% a year ago, but operating margin compressed to 11.1% from 11.1% (flat). The company has been profitable for the trailing twelve months, with EPS of $1.53 for the quarter. However, margins are below industry averages for specialty retail, reflecting high fixed costs and investment spending. The balance sheet shows high leverage: debt-to-equity is 65.5, and the current ratio is 1.19, indicating adequate liquidity but elevated debt. Free cash flow for the trailing twelve months was $249.6 million, with a free cash flow yield of 6.7% based on market cap. ROE is 2.06%, low due to high equity base, while ROA is 4.4%. The company generates positive operating cash flow ($96.1 million in Q4), but capital expenditures remain high ($44.2 million), limiting free cash flow generation.